Paul Sargos
Overview
Explore the profile of Paul Sargos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
1300
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alyamani N, Clementel E, Sargos P, Blanchard P, Supiot S, Ronchin P, et al.
Radiother Oncol
. 2025 Feb;
206:110780.
PMID: 39924002
Purpose: Radiotherapy quality assurance (RTQA) is essential for ensuring adherence to trial protocols. This paper summarizes the individual case review (ICR) results from the PEACE-1 trial, a phase-III study investigates...
2.
Le Guevelou J, Sargos P, Ost P, Alongi F, Arcangeli S, Berlin A, et al.
Clin Transl Radiat Oncol
. 2025 Jan;
51():100907.
PMID: 39845565
Purpose: In prostate cancer patients, high radiation doses to the urethra have been associated with an increased risk of severe genitourinary toxicity following dose-escalated radiotherapy. Urethra-sparing techniques have emerged as...
3.
« Augmented radiotherapy » in the management of high-risk prostate cancer (PCa): A systematic review
Le Guevelou J, Murthy V, Zilli T, Nicosia L, Bossi A, Bokhorst L, et al.
Crit Rev Oncol Hematol
. 2025 Jan;
207:104623.
PMID: 39827978
Background: In patients with high-risk (HR) prostate cancer (PCa) treated with radiotherapy and androgen deprivation therapy (ADT), intensification with androgen receptor pathway inhibitor (ARPI) improves overall survival (OS), at the...
4.
Ploussard G, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, et al.
Fr J Urol
. 2024 Nov;
34(12):102717.
PMID: 39581668
Objective: The aim of the Oncology Committee of the French Urology Association is to propose updated recommendations for the diagnosis and management of localized prostate cancer (PCa). Methods: A systematic...
5.
Ploussard G, Dariane C, Mathieu R, Baboudjian M, Barret E, Brureau L, et al.
Fr J Urol
. 2024 Nov;
34(12):102710.
PMID: 39581665
Purpose Of This Document: The Oncology Committee of the French Urology Association is proposing updated recommendations for the management of recurrent and/or metastatic prostate cancer (PCa). Methods: A systematic review...
6.
Roumiguie M, Marcq G, Neuzillet Y, Bajeot A, Allory Y, Sargos P, et al.
Fr J Urol
. 2024 Nov;
34(12):102741.
PMID: 39581664
Objective: To update the CCAFU recommendations for the management of muscle-invasive bladder cancer (MIBC). Methods: A systematic review (Medline) of the literature from 2022 to 2024 was carried out, taking...
7.
Bigot P, Boissier R, Khene Z, Albiges L, Bernhard J, Correas J, et al.
Fr J Urol
. 2024 Nov;
34(12):102735.
PMID: 39581661
Objective: To update the French recommendations for the management of kidney cancer. Methods: A systematic review of the literature was conducted for the period from 2014 to 2024. The most...
8.
Bossi A, Foulon S, Maldonado X, Sargos P, MacDermott R, Kelly P, et al.
Lancet
. 2024 Nov;
404(10467):2065-2076.
PMID: 39580202
Background: The 2 × 2 PEACE-1 study showed that combining androgen-deprivation therapy with docetaxel and abiraterone improved overall and radiographic progression-free survival in patients with de novo metastatic castration-sensitive prostate...
9.
Baudelin C, Sargos P, Dinart D, Hennequin C, Teyssonneau D, Meynard L, et al.
Crit Rev Oncol Hematol
. 2024 Nov;
205:104557.
PMID: 39580059
Background And Objective: For selected patients with muscle-invasive bladder cancer (MIBC), trimodal therapy (TMT) incorporating transurethral resection of the tumor and chemoradiotherapy is an alternative to radical cystectomy. Concurrent chemotherapy...
10.
Peyrottes A, Dariane C, Baboudjian M, Barret E, Brureau L, Fiard G, et al.
Eur Urol Oncol
. 2024 Nov;
PMID: 39562217
Background And Objective: The role of anatomical factors in predicting outcomes after radical prostatectomy (RP) remains unclear. This review aims to evaluate the impact of various anatomical factors on the...